• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.中国江苏省 COVID-19 患者的呼吸衰竭:一项多中心回顾性队列研究。
Epidemiol Infect. 2021 Jan 20;149:e31. doi: 10.1017/S0950268821000157.
2
Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.中国江苏省重症 COVID-19 患者的临床特征和危险因素:一项回顾性多中心队列研究。
BMC Infect Dis. 2020 Aug 6;20(1):584. doi: 10.1186/s12879-020-05314-x.
3
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
4
Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.入院时 CT 肺部不透明度评分与 COVID-19 患者临床特征和结局的关系。
Intern Emerg Med. 2022 Jan;17(1):153-163. doi: 10.1007/s11739-021-02795-9. Epub 2021 Jun 30.
5
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.中国浙江省 465 例新冠肺炎(COVID-19)住院病例的流行病学、临床和病毒学特征。
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19.
6
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
7
CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.COVID-19 呼吸衰竭的 CPAP 管理:来自住院服务评估的首次定量分析。
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000692.
8
Disease progression in patients with COVID-19: a retrospective cohort study in China.COVID-19 患者的疾病进展:中国的一项回顾性队列研究。
Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1032-1037. doi: 10.5588/ijtld.20.0386.
9
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
10
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.

引用本文的文献

1
Exploring the Prevalence of Respiratory Failure in Adults Presenting With Acute Exacerbations of Chronic Obstructive Pulmonary Disease.探索慢性阻塞性肺疾病急性加重期成人患者呼吸衰竭的患病率。
Cureus. 2024 Jun 27;16(6):e63334. doi: 10.7759/cureus.63334. eCollection 2024 Jun.
2
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
3
Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.新型冠状病毒肺炎患者严重程度和死亡的预后因素:系统评价。
PLoS One. 2020 Nov 17;15(11):e0241955. doi: 10.1371/journal.pone.0241955. eCollection 2020.

本文引用的文献

1
Disease progression in patients with COVID-19: a retrospective cohort study in China.COVID-19 患者的疾病进展:中国的一项回顾性队列研究。
Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1032-1037. doi: 10.5588/ijtld.20.0386.
2
Age differences in clinical features and outcomes in patients with COVID-19, Jiangsu, China: a retrospective, multicentre cohort study.中国江苏 COVID-19 患者的临床特征和结局的年龄差异:一项回顾性、多中心队列研究。
BMJ Open. 2020 Oct 5;10(10):e039887. doi: 10.1136/bmjopen-2020-039887.
3
Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.COVID-19 患者死亡率的流行情况及相关危险因素:一项荟萃分析。
J Community Health. 2020 Dec;45(6):1270-1282. doi: 10.1007/s10900-020-00920-x.
4
Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.经验性治疗抗凝与 COVID-19 所致呼吸衰竭危重症患者的死亡率:一项回顾性队列研究。
J Clin Pharmacol. 2020 Nov;60(11):1411-1415. doi: 10.1002/jcph.1749. Epub 2020 Sep 30.
5
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.回顾性分析高流量鼻导管通气在 COVID-19 相关中重度低氧血症性呼吸衰竭中的应用。
BMJ Open Respir Res. 2020 Aug;7(1). doi: 10.1136/bmjresp-2020-000650.
6
Risk Factors for Poor Outcome in Patients with Severe Viral Pneumonia on Chest CT during the COVID-19 Outbreak: a Perspective from Iran.COVID-19疫情期间胸部CT显示为重症病毒性肺炎患者预后不良的危险因素:来自伊朗的视角
SN Compr Clin Med. 2020;2(9):1366-1376. doi: 10.1007/s42399-020-00445-3. Epub 2020 Aug 19.
7
Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre.新型冠状病毒肺炎相关急性低氧性呼吸衰竭的无创通气:单中心经验
Br J Anaesth. 2020 Oct;125(4):e368-e371. doi: 10.1016/j.bja.2020.07.008. Epub 2020 Jul 21.
8
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study).开发和验证住院 SARS-CoV-2 感染患者严重呼吸衰竭预测模型:一项多中心队列研究(PREDI-CO 研究)。
Clin Microbiol Infect. 2020 Nov;26(11):1545-1553. doi: 10.1016/j.cmi.2020.08.003. Epub 2020 Aug 8.
9
Prediction model and risk scores of ICU admission and mortality in COVID-19.新型冠状病毒肺炎患者 ICU 入住和死亡的预测模型和风险评分。
PLoS One. 2020 Jul 30;15(7):e0236618. doi: 10.1371/journal.pone.0236618. eCollection 2020.
10
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.预测 COVID-19 不良预后的因素:系统评价和荟萃分析。
Eur J Clin Invest. 2020 Oct;50(10):e13362. doi: 10.1111/eci.13362. Epub 2020 Aug 27.

中国江苏省 COVID-19 患者的呼吸衰竭:一项多中心回顾性队列研究。

Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.

机构信息

Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing210009, China.

Department of Clinical Sciences, Liverpool School of Tropical Medicine, LiverpoolL3 5QA, UK.

出版信息

Epidemiol Infect. 2021 Jan 20;149:e31. doi: 10.1017/S0950268821000157.

DOI:10.1017/S0950268821000157
PMID:33468282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7853731/
Abstract

This study was a retrospective multicentre cohort study of patients with coronavirus disease 2019 (COVID-19) diagnosed at 24 hospitals in Jiangsu province, China as of 15 March 2020. The primary outcome was the occurrence of acute respiratory failure during hospital stay. Of 625 patients, 56 (9%) had respiratory failure. Some selected demographic, epidemiologic, clinical and laboratory features as well as radiologic features at admission and treatment during hospitalisation were significantly different in patients with and without respiratory failure. The multivariate logistic analysis indicated that age (in years) (odds ratio [OR], 1.07; 95% confidence interval [CI]: 1.03-1.10; P = 0.0002), respiratory rate (breaths/minute) (OR, 1.23; 95% CI: 1.08-1.40; P = 0.0020), lymphocyte count (109/l) (OR, 0.18; 95% CI: 0.05-0.69; P = 0.0157) and pulmonary opacity score (per 5%) (OR, 1.38; 95% CI: 1.19-1.61; P < 0.0001) at admission were associated with the occurrence of respiratory failure. Older age, increased respiratory rate, decreased lymphocyte count and greater pulmonary opacity score at admission were independent risk factors of respiratory failure in patients with COVID-19. Patients having these risk factors need to be intensively managed during hospitalisation.

摘要

这项研究是一项回顾性多中心队列研究,纳入了截至 2020 年 3 月 15 日中国江苏省 24 家医院诊断的 2019 年冠状病毒病(COVID-19)患者。主要结局是住院期间发生急性呼吸衰竭。在 625 例患者中,有 56 例(9%)发生呼吸衰竭。有呼吸衰竭和无呼吸衰竭的患者在一些选定的人口统计学、流行病学、临床和实验室特征以及入院时的影像学特征和住院期间的治疗方面存在显著差异。多变量逻辑分析表明,年龄(岁)(比值比[OR],1.07;95%置信区间[CI]:1.03-1.10;P = 0.0002)、呼吸频率(次/分钟)(OR,1.23;95%CI:1.08-1.40;P = 0.0020)、淋巴细胞计数(109/l)(OR,0.18;95%CI:0.05-0.69;P = 0.0157)和入院时的肺部混浊评分(每 5%)(OR,1.38;95%CI:1.19-1.61;P < 0.0001)与呼吸衰竭的发生相关。入院时年龄较大、呼吸频率增加、淋巴细胞计数减少和肺部混浊评分较高是 COVID-19 患者发生呼吸衰竭的独立危险因素。具有这些危险因素的患者在住院期间需要加强管理。